ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly net cash provided by operating activities ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows (Postgres DB)
Latest, Q2 2026
10,690
Period ended Jun 30, 2026
Change on a year earlier
+246.3%
3,087 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
50
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash provided by operating activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 10,690 | +246.3% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 5,333 | +220.1% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 3,225 | +30.3% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 8,835 | +138.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,087 | +110.5% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,666 | +42.9% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,474 | -892.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 3,712 | +69.5% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,466 | +132.0% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,166 | -32.6% | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | -312 | -118.8% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,190 | -1.2% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 632 | -46.6% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,731 | -31.4% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,663 | -26.5% | Form 10-K (filed 2024-02-21) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,217 | +35.9% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,183 | -33.4% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,523 | +48.6% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,262 | +24.6% | Form 10-K (filed 2024-02-21) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,631 | -9.7% | Form 10-Q (filed 2021-10-27) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,776 | -28.8% | Form 10-Q (filed 2021-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,697 | +343.9% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,815 | -7.6% | Form 10-K (filed 2021-02-17) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,807 | +19.6% | Form 10-Q (filed 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,495 | +137.3% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 382 | +22.8% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,964 | +35.5% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | 1,510 | -28.8% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,052 | -30.7% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 311 | -28.7% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,449 | -16.9% | Form 10-K (filed 2019-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,122 | +12.8% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 1,518 | -8.1% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | 437 | +28.4% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 1,744 | -13.1% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,881 | +13.2% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | 1,651 | +17.8% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 340 | -255.1% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | 2,007 | +101.4% | Form 10-Q (filed 2017-10-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 1,662 | +50.4% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2016 | Jun 30, 2016 | 1,402 | +47.8% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | -219 | +158.4% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2015 | Dec 31, 2015 | 996 | -30.9% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2015 | Sep 30, 2015 | 1,105 | -34.7% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 949 | -10.0% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | -84.8 | -131.1% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 1,441 | – | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2014 | Sep 30, 2014 | 1,691 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 1,054 | -35.6% | Form 10-Q (filed 2014-07-28) ↗ |
| Q1 2014 | Mar 31, 2014 | 272 | -28.2% | Form 10-Q (filed 2014-04-28) ↗ |
| Q2 2013 | Jun 30, 2013 | 1,637 | +25.4% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | 379 | -55.5% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | 1,602 | – | Form 10-K (filed 2013-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | 1,544 | -62.5% | Form 10-Q (filed 2012-10-26) ↗ |
| Q2 2012 | Jun 30, 2012 | 1,306 | – | Form 10-Q (filed 2012-07-27) ↗ |
| Q1 2012 | Mar 31, 2012 | 853 | -27.5% | Form 10-Q (filed 2012-04-30) ↗ |
| Q2 2011 | Sep 30, 2011 | 4,114 | +133.9% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | 1,176 | +22.8% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | 2,228 | +10.4% | Form 10-K (filed 2011-02-22) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,759 | +34.7% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | 1,912 | +107.0% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | 958 | +989.9% | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | 2,019 | -15.2% | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2009 | Sep 30, 2009 | 1,306 | -38.7% | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2009 | Jun 30, 2009 | 923 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q1 2009 | Mar 31, 2009 | 87.9 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2008 | Dec 31, 2008 | 2,381 | – | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2008 | Sep 30, 2008 | 2,132 | – | Form 10-Q (filed 2009-10-30) ↗ |
Breakdown
What makes up net cash provided by operating activities ($m)
- Depreciation and amortization ($M)534 · Q2 2026
- Stock-based compensation expense ($M)201 · Q2 2026
- Deferred income taxes ($M)–
- Change in receivables ($M)–
- Change in inventories ($M)–
- Change in accounts payable and other liabilities ($M)–
- Net cash used for investing activities ($M)-15,396 · Q2 2026
- Net cash provided by / (used for) financing activities ($M)8,426 · Q2 2026
- Effect of exchange rate changes on cash and equivalents ($M)-52 · Q2 2026
- Net increase / (decrease) in cash and cash equivalents ($M)3,668 · Q2 2026
Cite this data
StockData. (2026). Eli Lilly Net cash provided by operating activities ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_ocf
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.